vs

Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and SIMMONS FIRST NATIONAL CORP (SFNC). Click either name above to swap in a different company.

iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $197.3M, roughly 1.1× SIMMONS FIRST NATIONAL CORP). On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 19.6%). SIMMONS FIRST NATIONAL CORP produced more free cash flow last quarter ($411.4M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 0.6%).

iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.

Simmons Bank is a bank with operations in Arkansas, Kansas, Missouri, Oklahoma, Tennessee, and Texas. It is the primary subsidiary of Simmons First National Corporation, a bank holding company.

IRTC vs SFNC — Head-to-Head

Bigger by revenue
IRTC
IRTC
1.1× larger
IRTC
$208.9M
$197.3M
SFNC
Growing faster (revenue YoY)
IRTC
IRTC
+7.5% gap
IRTC
27.1%
19.6%
SFNC
More free cash flow
SFNC
SFNC
$396.9M more FCF
SFNC
$411.4M
$14.5M
IRTC
Faster 2-yr revenue CAGR
IRTC
IRTC
Annualised
IRTC
25.8%
0.6%
SFNC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRTC
IRTC
SFNC
SFNC
Revenue
$208.9M
$197.3M
Net Profit
$5.6M
Gross Margin
70.9%
Operating Margin
1.1%
Net Margin
2.7%
Revenue YoY
27.1%
19.6%
Net Profit YoY
518.5%
EPS (diluted)
$0.18
$0.36

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRTC
IRTC
SFNC
SFNC
Q4 25
$208.9M
$197.3M
Q3 25
$192.9M
$186.7M
Q2 25
$186.7M
$214.2M
Q1 25
$158.7M
$209.6M
Q4 24
$164.3M
$208.5M
Q3 24
$147.5M
$174.8M
Q2 24
$148.0M
$197.2M
Q1 24
$131.9M
$195.1M
Net Profit
IRTC
IRTC
SFNC
SFNC
Q4 25
$5.6M
Q3 25
$-5.2M
$-562.8M
Q2 25
$-14.2M
$54.8M
Q1 25
$-30.7M
$32.4M
Q4 24
$-1.3M
Q3 24
$-46.2M
$24.7M
Q2 24
$-20.1M
$40.8M
Q1 24
$-45.7M
$38.9M
Gross Margin
IRTC
IRTC
SFNC
SFNC
Q4 25
70.9%
Q3 25
71.1%
Q2 25
71.2%
Q1 25
68.8%
Q4 24
70.0%
Q3 24
68.8%
Q2 24
69.9%
Q1 24
66.3%
Operating Margin
IRTC
IRTC
SFNC
SFNC
Q4 25
1.1%
Q3 25
-4.4%
Q2 25
-10.0%
Q1 25
-20.5%
Q4 24
-2.5%
Q3 24
-34.1%
Q2 24
-15.5%
Q1 24
-28.9%
Net Margin
IRTC
IRTC
SFNC
SFNC
Q4 25
2.7%
Q3 25
-2.7%
-301.5%
Q2 25
-7.6%
25.6%
Q1 25
-19.3%
15.5%
Q4 24
-0.8%
Q3 24
-31.3%
14.1%
Q2 24
-13.6%
20.7%
Q1 24
-34.6%
19.9%
EPS (diluted)
IRTC
IRTC
SFNC
SFNC
Q4 25
$0.18
$0.36
Q3 25
$-0.16
$-4.00
Q2 25
$-0.44
$0.43
Q1 25
$-0.97
$0.26
Q4 24
$-0.03
$0.38
Q3 24
$-1.48
$0.20
Q2 24
$-0.65
$0.32
Q1 24
$-1.47
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRTC
IRTC
SFNC
SFNC
Cash + ST InvestmentsLiquidity on hand
$583.8M
Total DebtLower is stronger
$620.0M
Stockholders' EquityBook value
$152.7M
$3.4B
Total Assets
$1.0B
$24.5B
Debt / EquityLower = less leverage
0.18×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRTC
IRTC
SFNC
SFNC
Q4 25
$583.8M
Q3 25
$565.2M
Q2 25
$545.5M
Q1 25
$520.6M
Q4 24
$535.6M
Q3 24
$522.0M
Q2 24
$561.5M
Q1 24
$569.1M
Total Debt
IRTC
IRTC
SFNC
SFNC
Q4 25
$620.0M
Q3 25
$667.8M
Q2 25
$1.0B
Q1 25
$1.3B
Q4 24
$1.1B
Q3 24
$1.4B
Q2 24
$1.7B
Q1 24
$1.2B
Stockholders' Equity
IRTC
IRTC
SFNC
SFNC
Q4 25
$152.7M
$3.4B
Q3 25
$121.9M
$3.4B
Q2 25
$103.7M
$3.5B
Q1 25
$86.7M
$3.5B
Q4 24
$90.9M
$3.5B
Q3 24
$71.8M
$3.5B
Q2 24
$99.2M
$3.5B
Q1 24
$90.3M
$3.4B
Total Assets
IRTC
IRTC
SFNC
SFNC
Q4 25
$1.0B
$24.5B
Q3 25
$995.2M
$24.2B
Q2 25
$964.0M
$26.7B
Q1 25
$926.1M
$26.8B
Q4 24
$931.4M
$26.9B
Q3 24
$909.7M
$27.3B
Q2 24
$919.2M
$27.4B
Q1 24
$909.8M
$27.4B
Debt / Equity
IRTC
IRTC
SFNC
SFNC
Q4 25
0.18×
Q3 25
0.20×
Q2 25
0.28×
Q1 25
0.35×
Q4 24
0.32×
Q3 24
0.40×
Q2 24
0.50×
Q1 24
0.36×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRTC
IRTC
SFNC
SFNC
Operating Cash FlowLast quarter
$26.2M
$449.5M
Free Cash FlowOCF − Capex
$14.5M
$411.4M
FCF MarginFCF / Revenue
6.9%
208.5%
Capex IntensityCapex / Revenue
5.6%
19.3%
Cash ConversionOCF / Net Profit
4.70×
TTM Free Cash FlowTrailing 4 quarters
$34.5M
$717.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRTC
IRTC
SFNC
SFNC
Q4 25
$26.2M
$449.5M
Q3 25
$34.9M
$223.4M
Q2 25
$27.7M
$77.6M
Q1 25
$-7.9M
$32.8M
Q4 24
$19.2M
$425.9M
Q3 24
$24.3M
$199.4M
Q2 24
$11.8M
$86.1M
Q1 24
$-52.0M
$57.6M
Free Cash Flow
IRTC
IRTC
SFNC
SFNC
Q4 25
$14.5M
$411.4M
Q3 25
$20.1M
$216.7M
Q2 25
$17.3M
$66.3M
Q1 25
$-17.3M
$22.6M
Q4 24
$12.4M
$380.4M
Q3 24
$15.5M
$187.7M
Q2 24
$3.4M
$72.7M
Q1 24
$-61.8M
$47.7M
FCF Margin
IRTC
IRTC
SFNC
SFNC
Q4 25
6.9%
208.5%
Q3 25
10.4%
116.1%
Q2 25
9.3%
31.0%
Q1 25
-10.9%
10.8%
Q4 24
7.5%
182.5%
Q3 24
10.5%
107.4%
Q2 24
2.3%
36.9%
Q1 24
-46.8%
24.5%
Capex Intensity
IRTC
IRTC
SFNC
SFNC
Q4 25
5.6%
19.3%
Q3 25
7.7%
3.6%
Q2 25
5.6%
5.3%
Q1 25
5.9%
4.8%
Q4 24
4.2%
21.8%
Q3 24
6.0%
6.7%
Q2 24
5.7%
6.8%
Q1 24
7.4%
5.0%
Cash Conversion
IRTC
IRTC
SFNC
SFNC
Q4 25
4.70×
Q3 25
Q2 25
1.42×
Q1 25
1.01×
Q4 24
Q3 24
8.06×
Q2 24
2.11×
Q1 24
1.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IRTC
IRTC

Commercial Payors$111.7M53%
Centers For Medicare And Medicaid$49.2M24%
Healthcare Institutions$34.3M16%
Non Contracted Third Party Payors$13.7M7%

SFNC
SFNC

Segment breakdown not available.

Related Comparisons